Journal of Clinical Medicine (Jun 2023)

Interleukin-17A-Correlated Myocarditis in Patients with Psoriasis: Cardiac Recovery following Secukinumab Administration

  • Andrea Frustaci,
  • Nicola Galea,
  • Lorenzo Dominici,
  • Romina Verardo,
  • Maria Alfarano,
  • Rossella Scialla,
  • Antonio Giovanni Richetta

DOI
https://doi.org/10.3390/jcm12124010
Journal volume & issue
Vol. 12, no. 12
p. 4010

Abstract

Read online

(1) Background: Psoriasis (PS) is a common immune-mediated disease of the skin with possible extension to joints, aorta and eye. Myocardial inflammation has rarely been suggested. (2) Aims: Report of PS-related myocarditis. (3) Methods and Results: One hundred consecutive patients with PS were screened for cardiac involvement. Among them, five male patients (aged 56 ± 9.5 years) with a moderate–severe form of PS showed dilated cardiomyopathy (LVEF 50%) in the last 2 pts on SK. (4) Conclusions: IL-17A-related myocarditis can occur in up to 5% of patients with PS. It manifests as progressive dilated cardiomyopathy. It may completely recover following SK administration.

Keywords